Alto Neuroscience, Inc. (NYSE:ANRO) Receives $15.40 Average Price Target from Analysts
Alto Neuroscience, Inc. (NYSE:ANRO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price […]
Alto Neuroscience, Inc. (NYSE:ANRO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month target price […]
